Transforming growth factor-beta 1 (TGF-b1) arrests intestinal epithelial cells (RIE-1 and IEC-6) in the G1 phase of the cell cycle and inhibits cyclin D1 expression. This report describes experiments designed to elucidate the mechanism of cyclin D1 inhibition and to determine whether inhibition of cyclin D1 expression is the cause, rather than the result, of TGF-b1-mediated cell cycle arrest. TGF-b1 inhibition of IEC-6 cell proliferation was associated with a decrease in the abundance of cyclin D1/Cdk4 complexes and a corresponding decrease in Cdk4-dependent phosphorylation of the retinoblastoma protein. Metabolic labeling studies indicated that TGFb1 inhibited cyclin D1 synthesis without altering the rate of cyclin D1 protein degradation. Cyclin D1 antisense oligonucleotides blocked serum-stimulated induction of cyclin D1 and DNA synthesis, whereas cyclin D1 sense oligonucleotides had no eect. RIE-1 cells were engineered to overexpress human cyclin D1 under the control of a tetracycline-repressible promoter. These cells entered S phase in the presence of TGF-b1 only when human cyclin D1 was derepressed by the withdrawal of tetracycline. These data indicate that TGF-b1 inhibits the synthesis of cyclin D1 in gut epithelial cells and that this inhibition is the cause, rather than the result, of TGF-b1-mediated arrest of intestinal epithelial cell proliferation.
Introduction
Intestinal epithelial cells are among the most rapidly proliferating cells in the adult mammal, and it has been estimated that the epithelial mucosa of the gut is completely replaced every 3 ± 8 days (Cairnie et al, 1965; Cheng and Leblond, 1974) . Renewal of the intestinal epithelium is a complex process. Cell proliferation is restricted to a subpopulation of enterocytes located in the crypts at the bases of the villi (Babyatsky and Podolsky, 1991) . Mitotic activity ceases as cells migrate out of the crypts, and there is a concomitant increase in the expression of a number of dierentiated gene products (Gordon et al., 1992; Traber, 1994) . Dierentiated enterocytes are removed by the process of apoptosis which occurs throughout the villus and by exfoliation which occurs at the villus tip (Gavrieli et al., 1992; Hall et al., 1994; Chandrasekaran et al., 1996) .
Many dierent signals contribute to those phenotypic changes that are associated with maturation of the gut epithelium. One such signal consists of an autocrine/paracrine regulatory loop that involves transforming growth factor-beta 1 (TGF-b1). Enterocytes begin to synthesize TGF-b1 soon after they migrate from the intestinal crypts (Barnard et al., 1989 (Barnard et al., , 1993 . The hormone is secreted in an inactive form and is activated in the extracellular milieu. Activated TGFb1 inhibits enterocyte proliferation and stimulates dierentiation and migration of these epithelial cells (Kurokowa et al., 1987; Ciacci et al., 1993; Ko et al., 1994) .
Interest in the molecular basis of TGF-b1 regulation of cell proliferation is entrained by the fact that this is one of the few hormones that inhibits mitotic activity. Beyond that, there is compelling evidence that loss of TGF-b1 responsiveness is associated with malignant transformation of gut epithelial cells. Loss of TGF-b1 responsiveness is characteristic of the transition from adenoma to adenocarcinoma of colonic epithelium (Hoosein et al., 1989; Manning et al., 1991) . Expression of mutated ras alleles is characteristic of colorectal cancers (Bos et al., 1987) , and such alleles convey resistance to TGF-b1 inhibition of cell proliferation in culture (Filmus et al., 1992) . Some cancer cells are deleted of the TGF-b type II receptor, and reconstitution of type II receptor expression can attenuate the transformed phenotype (Inagaki et al., 1993; Sun et al., 1994; Markowitz et al., 1995; Wang et al., 1995) . Observations such as these indicate that TGF-b1 is an important physiological regulator of intestinal cell proliferation, and loss of TGF-b1 responsiveness has a profound pathological signi®cance. Consequently, the molecular mechanism of action of TGF-b1 on intestinal epithelial cell proliferation has become a topic of considerable interest.
Analysis of TGF-b1 inhibition of intestinal epithelial cell proliferation has been facilitated by the availability of two well-characterized, non-transformed rat intestinal epithelial cell lines, IEC-6 and RIE-1 (Quaroni et al., 1979; Brown, 1984, 1985) . Mid-log phase cultures of either cell line cease to proliferate when exposed to TGF-b1 (Barnard et al., 1989; Ko et al., 1994 Ko et al., , 1995 . TGF-b1-treated intestinal epithelial cells arrest with a G1 DNA content; and TGF-b1 blocks DNA synthesis that normally occurs when serumstarved, quiescent cells are stimulated by the addition of serum growth factors (Ko et al., , 1995 . TGFb1-treated cells still exhibit an immediate early response upon serum stimulation, but fail to progress beyond mid to late G1 . If addition of TGF-b1 is delayed until serum-stimulated cells have reached late G1, the hormone cannot thereafter prevent initiation of DNA replication . These data are consistent with the hypothesis that TGF-b1 inhibits the expression of some critical G1 progression factor(s) that is normally expressed in mid G1.
Progression through early to mid G1 is dependent upon the activation of cyclin-dependent kinase Cdk4, which requires association with one of the D-type cyclins, D1, D2 or D3 (reviewed in Hunter and Pines, 1994; Sherr, 1994) . The three D-type cyclins have variable expression, depending on cell types (Ajchenbaum et al., 1993; Palmero et al., 1993) . Cyclin D1 and cyclin D3 are the major forms expressed in rat intestinal epithelial cells (Ko et al., 1995) . The only known substrate for the activated Cdk4 is the retinoblastoma protein, pRB (Matsushime et al., 1992; Dowdy et al., 1993; Kato et al., 1993) . In its hypophosphorylated form, pRB can bind and inhibit transcription factors, including heterodimers of the E2F and DP families of proteins (Farnham et al., 1993; Flemington et al., 1993) . Phosphorylation of pRB during G1 leads to release of E2F/DP and subsequent activation of genes that participate in S phase entry (Farnham et al., 1993; Huber et al., 1993; Lam and La Thangue, 1994) .
In all epithelial cells studied to date, TGF-b1 induces G1 arrest by inhibiting Cdk4 activity and preventing pRB phosphorylation, although dierent cell types appear to manifest dierent primary responses. TGF-b1 inhibits Cdk4 synthesis in mink lung epithelial cells without altering expression of Dtype cyclins (Ewen et al., , 1995 ; whereas TGF-b1 induces a Cdk4 inhibitor (p15
INK4B
) in human keratinocytes and mammary epithelial cells without altering expression of D-type cyclins or Cdk4 (Hannon and Beach, 1994; Reynisdottir et al., 1995; Sandhu et al., 1997) . In gut epithelial cells, TGF-b1 inhibits cyclin D1 expression without altering expression of cyclin D3 or Cdk4 (Ko et al., 1995) , suggesting that inhibition of Cdk4 activation during G1 progression may result from failure to induce cyclin D1. the net eect is the same in all epithelial cell types studied to date: a decrease in the activity of the cyclin D/Cdk4 complexes leading to G1 arrest. Nevertheless, the observation that TGF-b1 blocks cell proliferation by dierent mechanisms in dierent cell types raises a question concerning the causes of G1 arrest versus the eects of G1 arrest in gut epithelial cells. The experiments described below were carried out to elucidate the mechanism responsible for TGF-b1 regulation of Cdk4 activity in gut epithelial cell lines. The results indicate that such inhibition is due to a decrease in the rate of synthesis of cyclin D1, with a corresponding decrease in the abundance of cyclin D1/Cdk4 complexes, leading to inhibition of Cdk4-dependent phosphorylation of the retinoblastoma protein. Inhibition of cyclin D1 expression by antisense oligonucleotides mimics the eects of TGF-b1 and these eects can be attenuated by overexpression of cyclin D1. The results of these experiments indicate cyclin D1 is the target by which TGF-b1 causes G1 arrest of intestinal epithelial cells. This mechanism is fundamentally dierent from those that account for TGF-b1 inhibition of keratinocytes, mink lung epithelial cells and breast epithelial cells.
Results
TGF-b1 inhibits cyclin D1 expression, the abundance of cyclin D1/Cdk4 complexes and Cdk4-associated kinase activity TGF-b1 is a potent inhibitor of gut epithelial cell proliferation and blocks cell cycle progression during G1 phase (Ko et al., , 1995 . TGF-b1 inhibition of DNA synthesis in rat intestinal epithelial cells is associated with suppression of cyclin D1 expression, as shown in Figure 1 . In this experiment, quiescent cultures were stimulated by addition of serum in the presence or absence of TGF-b1. Cells were stimulated for 18 h (which corresponds to the peak of S phase), and cultures were labeled by addition of [ Figure 1 indicate that TGF-b1 inhibits cyclin D1 expression and blocks 3 H-thymidine labeling. Previously, we have shown that suppression of cyclin D1 occurs within 2 h after TGF-b1 treatment, which precedes inhibition of DNA synthesis by at least 6 h (Ko et al., 1995) . Taken together, these data strongly suggest that cyclin D1 reduction may be the cause of TGF-b1 induced growth inhibition rather than the consequence of G1-arrest.
If cyclin D1 is the limiting subunit of the cyclin/Cdk holoenzyme, then inhibition of cyclin D1 expression should be associated with a decrease in the amount of cyclin D1 bound to Cdk4. In the experiment shown in Figure 2a , protein extracts from control and TGF-b1-treated cells were precipitated with an anti-Cdk4 antibody (IPaCdk4), and the immunocomplexes were assayed for the amount of cyclin D1 (CcnD1) bound to Cdk4. The reciprocal experiment was performed by precipitating with anti-cyclin D1 antibody (IPaCcnD1) and analysing the immunocomplexes for the amount of Cdk4 bound to cyclin D1. In both experiments, the abundance of cyclin D1/Cdk4 complexes was reduced by 60 ± 70% in TGF-b1-treated cells compared to control. IEC-6 cells also expressed cyclin D3; however, the levels of cyclin D3 protein (Ko et al., 1995) and cyclin D3/Cdk4 complexes were not altered after TGF-b1 treatment (data not shown).
Cdk4-dependent phosphorylation of pRB was also inhibited by TGF-b1, as shown in Figure 2b . In this experiment, protein extracts from control and TGF-b1-treated cells were initially precipitated with anti-Cdk4 antiserum (IPaCdk4), and the immunocomplexes were assayed for the ability to phosphorylate recombinant pRB. Treatment with TGF-b1 resulted in an 80% inhibition of Cdk4-associated kinase activity in IEC-6 cells. These results suggest that TGF-b1 must inactivate both cyclin D1/Cdk4 and cyclin D3/Cdk4. Cyclin D1/Cdk4 is inactivated by virtue of a decrease in complex formation ( Figure 2a) ; however, cyclin D3/ Cdk4 must be suppressed by a separate mechanism since TGF-b1 had no eect on the abundance of cyclin D3/Cdk4 complexes. In human keratinocytes and mammary breast epithelial cells, TGF-b1 inactivates cyclin D-associated kinase by inducing a Cdk4 inhibitor ( p15 INK4B ) (Reynisdottir et al., 1995; Sandhu et al., 1997) . We were unable to detect p15 INK4B in TGF-b1-treated IEC-6 cells, although we can easily detect this inhibitor in mink lung epithelial cells. We were able to detect expression of two universal Cdk inhibitors, p21 (Harper et al., 1993; El-Deiry et al., 1993; Xiong et al., 1993) and p27 (Polyak et al., 1994 ; Figure 2 The abundance of cyclin D1/Cdk4 complexes, Cdk4-associated kinase activity and cyclin D3/p27 in TGF-b1-treated cells. Serum-starved, quiescent IEC-6 cultures were stimulated with 5% FBS with vehicle (7) or TGF-b1 (+). (a) Protein lysates were precipitated with anti-Cdk4 antibody (IPaCdk4) or anti-cyclin D1 antibody (IPaCcnD1), and the immunocomplexes were resolved by SDS ± PAGE. The resulting ®lters were immunoblotted using antibodies against cyclin D1 (CcnD1) or Cdk4. (b) Protein lysates were immunoprecipitated with anti-Cdk4 antiserum. The immunocomplexes were incubated with recombinant GST-pRB plus [g-32 P]ATP. The labeled products of the kinase rection were resolved by SDS ± PAGE and detected by autoradiography. (c) Protein lysates were precipitated with anti-cyclin D3 antibody (IPaCcnD3) or anti-p27 antibody (IPap27) and the immunocomplexes were resolved by SDS ± PAGE. The resulting ®lters were immunoblotted using antibodies against p27 or cyclin D3 (CcnD3) Toyoshima and Hunter, 1994) in IEC-6 cells. TGF-b1 treatment resulted in an increased amount of p27 bound to cyclin D3 as shown in Figure 2c . This ®nding was con®rmed by the reciprocal experiment which demonstrated an increased amount of cyclin D3 bound to p27. In both experiments, the abundance of cyclin D3/p27 complexes was induced 2 ± 3-fold in TGF-b1-treated cells compared to control. We were unable to detect any p21 bound to cyclin D3 and vice versa. These results suggest that increased binding of p27 to cyclin D3 may be a possible mechanism for inactivation of cyclin D3/Cdk4 kinase activity.
TGF-b1 inhibits the synthesis of cyclin D1
Methionine labeling experiments were carried out to determine whether TGF-b1 inhibition of cyclin D1 expression is due to a decrease in the rate of protein synthesis or an increase in the rate of protein degradation. Cells were treated with TGF-b1 or vehicle control for 6 h and labeled with 35 S-methionine during the last 3 h of treatment. Protein extracts from control and TGF-b1-treated cells were resolved by electrophoresis and immunoblotted to determine steady-state levels of cyclin D1 and Cdk4 ( Figure 3a) . Protein extracts were also precipitated with antibodies against cyclin D1 or Cdk4, separated by electrophoresis and visualized by autoradiography to determine de novo protein synthesis (Figure 3b ). TGF-b1 inhibited both the abundance and synthesis of cyclin D1 by at least 80% but did not alter the abundance or the synthesis of cyclin D3 (data not shown). TGF-b1 inhibited neither the abundance (Figure 3a) nor the synthesis (Figure 3b ) of Cdk4.
Pulse-chase experiments were performed to determine whether TGF-b1 alters the rate of cyclin D1 degradation. Cells were labeled with 35 S-methionine for 3 h in the presence or absence of TGF-b1. Thereafter, the labeled amino acid was removed from the culture medium and unlabeled methionine added. The abundance of 35 S-methionine-labeled cyclin D1 was determined by immunoprecipitation of protein extracts prepared at intervals after removal of the radioactive amino acid, as shown in Figure 3c . The data indicate that, in the absence of TGF-b1, the T 1/2 of cyclin D1 degradation was about 20 min, which is similar to that reported from other cell lines (Matsushime et al., 1992) . Addition of TGF-b1 had no signi®cant eect on cyclin D1 turnover. These results have been con®rmed by measuring cyclin D1 protein abundance as a function of time after addition of cycloheximide (data not shown). The metabolic labeling data indicate that TGF-b1 inhibited cyclin D1 synthesis without altering the rate of cyclin D1 protein degradation.
Cyclin D1 antisense oligonucleotide blocks cyclin D1 expression and S phase progression TGF-b1 inhibits cyclin D1 synthesis in gut epithelial cells, leading to a decrease in the amount of cyclin D1/ Cdk4 complexes and inhibition of pRB phosphorylation. Phosphorylation of pRB by Cdk4 is essential for initiation of S phase (Connell-Crowley et al., 1997), and it is reasonable to assume that inhibition of cyclin S-methionine for 3 h in the presence of vehicle (Control) or TGF-b1. Protein lysates were prepared at the indicated times after the addition of unlabeled methionine. Sample aliquots were precipitated with anti-cyclin D1 antibody and resolved by SDS ± PAGE. Cyclin D1 protein was detected by autoradiography and quanti®ed by densitometry. The results are expressed as % of 0 min, where the amount of labeled cyclin D1 that was detected at the time of addition of unlabeled methionine is set at 100% D1 expression leads to cell cycle arrest of TGF-b1-treated intestinal epithelial cells. However, the data shown above do not preclude the possibility that inhibition of cyclin D1 expression is the result, rather than the cause, of cell cycle arrest. Two lines of experimentation have been pursued to test the hypothesis that inhibition of cyclin D1 expression is both necessary and sucient to preclude entry into S phase. The ®rst approach involves the use of synthetic oligodeoxyribonucleotides to inhibit the induction of cyclin D1 in serum-stimulated cells.
Synthetic oligonucleotides corresponding to sense and antisense sequences around the translational start site of rat cyclin D1 mRNA were prepared, as described in Materials and methods. These reagents were initially tested for inhibition of [ 3 H]thymidine incorporation as a function of concentration upon addition to mid-log phase cultures. It was determined that antisense oligonucleotides inhibited DNA synthesis at concentrations below 10 mM, whereas sense oligonucleotides had no signi®cant eect on [ 3 H]thymidine incorporation at similar concentrations (data not shown). Next, quiescent cultures were stimulated with serum in the presence of TGF-b1 or oligonucleotides. These conditions were used because they synchronized the cell culture, resulting in a more uniform response than asynchronous, mid-log phase cultures. Representative data are shown in Figure 4 . The immunoblotting data in Figure 4a illustrate the consistent observation that serum stimulation of quiescent culture caused a three to ®vefold induction of cyclin D1 (compare lanes 1 and 2), which was blocked by addition of TGF-b1 (lane 3). The (Figure 4b, fourth bar) . Cyclin D3 expression was measured to control for non-speci®c eects of synthetic oligonucleotides. As shown in Figure 4a , neither sense nor antisense oligonucleotides had any signi®cant eect upon cyclin D3 expression under the conditions that were employed in these experiments. The antisense oligonucleotide data indicate that inhibition of cyclin D1 expression is sucient to prevent G1 progression in gut epithelial cells. Similar data have been reported for serum-stimulated ®broblasts (Hung et al., 1996) .
Overexpression of cyclin D1 attenuates TGF-b1 induced G1 block
The antisense results are consistent with the working hypothesis that TGF-b1 inhibition of cyclin D1 expression causes G1 arrest of intestinal epithelial cells. A second prediction of this hypothesis is that overexpression of cyclin D1 should attenuate the eects of TGF-b1. To test this prediction, intestinal epithelial cells were engineered to express exogenous cyclin D1. All of these studies were performed with RIE-1 cells, which are also sensitive to TGF-b1 (Ko et al., 1995) and are much more readily transfected than IEC-6.
Two RIE-1 clones that overexpress human cyclin D1 under the control of a tetracycline-repressible promoter have been analysed in detail and both yield identical results. Figure 5 contains representative data from one of these clones, RIE-1/13, which has been transfected with a recombinant expression vector contains only the coding sequences of human cyclin D1 (being deleted of the 3 kb 3' untranslated region). This cell line expressed both the endogenous rat cyclin D1 transcript, which is about 4.3 kb in length, and the truncated human cyclin D1 transcript which is about 1.9 kb in length ( Figure  5a ). Addition of 0.1 mg/ml tetracycline reduced the abundance of the human transcript by about 90% with no signi®cant eect upon the endogenous, rat cyclin D1 mRNA (Figure 5a ). Tetracycline also inhibited human cycline D1 protein expression, as shown in Figure 5b . Polyclonal anti-human cyclin D1 antibody was used in this immunoblotting experiment. These data demonstrate that RIE-1/13 cells overexpress human cyclin D1 in the absence of tetracycline.
RIE-1/13 cells were analysed for sensitivity to TGFb1-mediated inhibition of cell cycle progression from G0 state into S phase. RIE-1 cells transfected with the tet-bgal expression vector served as control. Representative data are shown in Figure 6 , in which RIE-1/13 cells are designated tet-D1 and RIE-1/b-gal cells are designated tet-bgal. Quiescent RIE-1/13 cells in the presence of tetracycline expressed very little human cyclin D1 protein (Figure 6a, lane 1) . When these cells were released from G0 in the absence of tetracycline (so as to de-repress the tet-D1 transgene), induction of human cyclin D1 was observed (lane 2). The data shown in Figure 6a were obtained 6 h after serum stimulation, when the endogenous cyclin D1 is maximally induced (Ko et al., 1995) . Induction of human cyclin D1 did not occur when cells were released from G0 in the presence of tetracycline (lane 3). As expected, no human cyclin D1 was detected in RIE-1/b-gal cells, irrespective of the presence or absence of tetracycline (lanes 4 ± 6). Neither tetracycline nor TGF-b1 had any eect upon Cdk4 expression in any of the RIE-1-derived cell lines Figure 6a) .
Overexpression of human cyclin D1 in RIE-1/13 cells profoundly in¯uenced the manner in which these cells respond to TGF-b1, as shown in Figure 6b . Both RIE-1/13 and RIE-1/b-gal cells were treated with serum plus TGF-b1 in the presence or absence of tetracycline. Progression from G0 into S phase was monitored by¯ow cytometric analysis of DNA content at the peak of S phase, which occurs about 16 h after cells were released from G0. The percentage of RIE-1/ 13 cells in S phase increased about ®vefold in the absence of tetracycline and in the presence of TGF-b1 (compare the ®rst two bars in Figure 6b ). However, no signi®cant increase in S phase cells was observed when RIE-1/13 cells were released from G0 in the presence of tetracycline plus TGF-b1 (third bar, Figure 6b ). Identical results were obtained with RIE-1/9 cells, which also overexpress human cyclin D1 from a stably integrated tetracycline repressible expression vector. The culture growth properties of these cell lines are described in Sakai, Yu, Ko, and Thompson, in preparation. RIE-1/b-gal cells did not progress into S phase when released from G0 in the presence of TGFb1, irrespective of the presence or absence of tetracycline (Figure 6b ). These results indicate that Figure 5 Conditional overexpression of human cyclin D1 mRNA and protein in RIE-1/13 cells. RIE-1/13 cells overexpress human cyclin D1 under the control of a tetracycline-repressible promoter and were maintained in mid-log phase without (7) or with (+) 0.1 mg/ml tetracycline for 24 h. Cells were extracted to prepare total RNA or total protein. (a) Aliquots of total RNA were resolved by denaturing agarose gel electrophoresis and blotted onto nitrocellulose membranes. mRNA for rat cyclin D1 (rCcnD1) and human cyclin D1 (hCcnD1) were detected by probing the membrane with labeled human cyclin D1 cDNA. (b) Aliquots of protein lysates were resolved by SDS ± PAGE and immunoblotted with a polyclonal antibody against human cyclin D1 Figure 6 Conditional overexpression of cyclin D1 attenuates TGF-b1 inhibition of progression into S phase. (a) RIE-1/13 cells (tet-D1, lanes 1 ± 3) and RIE-1/b-gal cells (tet-bgal, lanes 3 ± 6) were grown to con¯uency and then serum starved to achieve quiescence (lanes 1 and 4). Cells were subcultured in 5% FBS plus TGF-b1 in the absence (lanes 2 and 5) or presence (lanes 3 and 6) of tetracycline (0.1 mg/ml). Protein lysates were resolved by SDS ± PAGE and assayed for human cyclin D1 (hCcnD1) or rat Cdk4 expression by immunoblotting. (b) Parallel cultures were treated as described above. Cells were harvested, stained with propidium iodide and analysed for percentage of S phase by¯ow cytometry. The data are derived from a representative experiment in which each bar represents the mean of three independent cultures+standard deviation overexpression of exogenous cyclin D1 can overcome the G1 block exerted by TGF-b1.
Discussion
TGF-b1 inhibits cell proliferation by dierent molecular mechanisms in dierent types of epithelial cells. In mink lung epithelial cells, the eects of the hormone appear to be due, in some degree, to a decrease in the translational eciency of Cdk4 mRNA (Ewen et al., 1995) . Suppression of Cdk4 synthesis reduces the abundance of cyclin D/Cdk4 complexes, thereby inhibiting Cdk4-dependent pRB phosphorylation (Laiho et al., 1990; Munger et al., 1992) . In contrast, TGF-b1 induces the expression of a Cdk4 inhibitor, p15
INK4B
, in human keratinocytes (Hannon and Beach, 1994) , mink lung epithelial cells (Reynisdottir et al., 1995) and human breast epithelial cells (Sandhu et al., 1997) . the accumulation of p15 INK4B causes a decrease in the amount of active Cdk4 in these cell types, and G1 arrest ensues. We have been unable to detect p15
in TGF-b1-treated IEC-6 or RIE-1 cells, although we can easily detect this inhibitor in mink lung epithelial cells. Consequently, we are unable to demonstrate any role for p15 INK4B in TGF-b1 inhibition of intestinal epithelial cells. Furthermore, TGF-b1 has no eect upon the expression of Cdk4 in gut epithelial cells, suggesting that inhibition of Cdk4 synthesis is not a probable cause of G1 arrest in this cell type.
Among epithelial cells, the intestinal cell lines uniquely exhibit a TGF-b1-mediated decrease in the abundance of cyclin D1 (Ko et al., 1995) . This is due to a decrease in the rate of synthesis of cyclin D1 in TGF-b1-treated cells, with no change in the rate of cyclin D1 degradation. Cyclin D1 exhibits a very rapid turnover rate in gut epithelial cells, so that the TGFb1-mediated decrease in cyclin D1 synthesis is attended by a corresponding decrease in the abundance of cyclin D1/Cdk4 complexes. There is a corresponding decrease in Cdk4-dependent pRB kinase activity. The eect upon cyclin D1 synthesis is speci®c, as evidenced by the observation that TGF-b1 has no eect upon the synthesis of cyclin D3 or Cdk4 in gut epithelial cells. Negative regulation of cyclin D1 has also been observed in other cell types following treatment with anti-mitogens. For example, anti-estrogen treatment in human breast cancer cells reduces cyclin D1 expression 8 h before inhibition of growth (Musgrove et al., 1993) and cAMP treatment in hamster ®broblasts decreases cyclin D1 expression without altering cyclin D3 or Cdk4 levels (L'Allemain et al., 1997). Furthermore, overexpression of cyclin D1 can partially alleviate the anti-proliferative eects of cAMP on hamster fibroblasts (L'Allemain et al., 1997). These ®ndings suggest that cyclin D1 is a selective target of various antiproliferative agents in dierent cell types including TGF-b1 in rat intestinal epithelial cells.
Three sets of data argue that TGF-b1 inhibition of cyclin D1 expression is the cause, rather than the result, of G1 arrest. The initial clue came from kinetic studies of cyclin D1 induction following serum stimulation of quiescent intestinal epithelial cells (Ko et al., 1995) . Cyclin D1 is induced three-to ®vefold under these circumstances, with the abundance of the cyclin reaching a maximum in mid G1, about 6 ± 9 h after stimulation. The increased cyclin D1 expression is associated with abundant cyclin D1/Cdk4 complex and Cdk4-dependent pRB kinase activity, as shown in Figure 2 . We have previously observed that addition of TGF-b1 prior to this time causes G1 arrest, whereas addition of TGF-b1 thereafter has little or no eect on entry into S phase . These observations suggest that there is a TGF-b1 restriction point that coincides with the induction of cyclin D1. According to this hypothesis, TGF-b1 blocks cyclin D1 induction, but cells are resistant to TGF-b1 after cyclin D1 has been induced and Cdk4 has been activated.
The present study has been designed to test two predictions that emanate from the hypothesis that TGF-b1 inhibition of intestinal epithelial cell growth is due to inhibition of cyclin D1 expression. The ®rst prediction is that inhibition of D1 expression should suce to prevent G1 progression. We have shown that blocking cyclin D1 expression by antisense oligonucleotides will prevent cell cycle progression and entry into S phase. The second prediction is that overexpression of cyclin D1 should attenuate the eects of TGF-b1. The results obtained with cells that overexpress human cyclin D1 under the control of the tetracycline-repressible promoter con®rm this prediction. The simplest interpretation of these data is that TGF-b1 inhibits intestinal epithelial cell proliferation by virtue of its ability to inhibit cyclin D1 synthesis.
Intestinal epithelial cells appear to be unique in that TGF-b1 inhibits their proliferation by regulating the expression of cyclin D1. TGF-b1 appears to be an important physiological aector of intestinal epithelial regeneration and dierentiation (Kurokowa et al., 1987; Barnard et al., 1989; Ko et al., 1994) . Furthermore, establishment of a link between TGFb1 and cyclin D1 provides an important clue into the etiology of epithelial neoplasia in the gut. It has been known for some time that loss of TGF-b1 responsiveness occurs during malignant transformation of colonic epithelial cells (Hoosein et al., 1989; Manning et al., 1991) . This insensitivity to the negative growth control by TGF-b1 may be due to mutations in its receptors or its signaling proteins (i.e. the MAD and MAD-related proteins), which have been identi®ed in approximately 15% of colorectal cancers Eppert et al., 1996; MacGrogan et al., 1997) . TGF-b type II receptor expression is decreased in intestinal adenomas of mouse with germline mutation in the APC gene and is associated with increased expression of cyclin D1 and Cdk4 (Zhang et al., 1997a, b) . These observations suggest that loss of TGF-b1 responsiveness de-represses cyclin D1. Recently, it has been determined that overexpression of cyclin D1 is an early event in the development of colon cancer. Cyclin D1 protein is overexpressed in approximately 30% of both human colon cancers and adenomatous polyps of the colon (Bartkova et al., 1994; Arber et al., 1996) . The resultant overexpression of cyclin D1 then predisposes the epithelial cells to transformation by some mechanism that remains obscure. Stable expression of antisense cyclin D1 in colon cancer cells results in decreased cell proliferation and a loss of tumorigenicity in nude mice (Arber et al., 1997) . We submit that a more thorough understanding of the mechanism(s) that account for TGF-b1 regulation of cyclin D1 expression in gut epithelial cells may provide new understanding of the processes that account for overexpression of cyclin D1 in pre-maligant cells. Additional studies will be required to understand how overexpression of cyclin D1 contributes to the development of cancer in the colon.
Materials and methods

Cell culture
The rat intestinal epithelial cell line IEC-6 was obtained from American Type Culture Collection (Rockville, MD). the RIE-1 cell line was obtained from Dr. Raymond DuBois (Vanderbilt University Medical Center, Nashville, TN). Both cell lines were maintained in Dulbecco's modi®ed Eagle medium (DMEM) containing 5% (vol/ vol) fetal bovine serum (FBS, Life Technologies, Inc., Grand Island, NY) in a 5% CO 2 incubator at 378C. As appropriate, mid-log phase cultures containing 6610 The following protocols were used in those experiments in which quiescent cells were subjected to serum stimulation. IEC-6 cells were grown to subcon¯uence and then serum deprived for 48 h . Quiescent cells were stimulated with addition of 5% FBS. Cell cycle progression was monitored by [ 3 H]thymidine incorporation into trichloroacetic acid-insoluble material, as previously described . RIE-1 cells were grown to con¯uence and then refed with fresh DMEM plus 5% FBS. After one day, cultures were incubated in serum-free DMEM for 2 days to obtain achieve quiescence. Con¯uent, serum-starved RIE-1 cells were harvested with trypsin and then split 1 : 4 in DMEM with 5% FBS. Cell cycle progression was assessed by quantitating DNA content by¯ow cytometry, as previously described (Bresnahan et al., 1996) . Propidium iodide-stained nuclei (10 000 per sample) were analysed by FACScan (Becton Dickson, San Jose, CA), and the percentage of S phase population of cells was determined by Mod®t LT program (Verity, ME). Under these conditions, the peak of S phase was observed 15 ± 18 h after release from quiescence in both IEC-6 cells and RIE-1 cells (data not shown).
RIE-1 cells were stably co-transfected with pUHD15-1neo and tet-D1 plasmids (5 mg each per 6 cm plate) using calcium phosphate (Frost et al., 1993) . The pUHD15-1neo contains the tetracycline-repressible chimeric transcription factor tTA (Gossen and Bujard, 1992) and tet D1 is a derivative of pUHD10-3 (Gossen and Bujard, 1992 ) that contains human cyclin D1 coding sequences under the control of a tetracycline-repressible promoter (Resnitsky et al., 1994) . Clonal, G418-resistant colonies were screened for tetracycline repression of human cycline D1 protein expression. Two clones, RIE-1/9 and RIE-1/13, were selected for further analysis based upon their sensitivity to tetracycline repression. A control cell line was also constructed in which cells were stably co-transfected with pUHD15-1neo and tet-bgal plasmids, which contain tetracycline repressible b-galactosidase instead of human cyclin D1. These control cells were used uncloned and are called RIE-1/bgal.
Cyclin D1 antisense oligonucleotide
A 20-base antisense oligonucleotide was designed to complement the translation initiation codon region (AUG) of the rat cyclin D1 mRNA (CCGCTCCATG-GAACACCAGC). Nucleotide phosphorothioates were incorporated at both the 5' and 3' three terminal residues to inhibit exonucleolytic degradation (Stein et al., 1988) . As control for nonspeci®c eects, a complementary oligonucleotide that corresponds to the`sense' cyclin D1 sequence was also synthesized. Oligonucleotides were synthesized by Genosys Biotechnologies, Inc. (The Woodlands, TX) and puri®ed by high-phase liquid chromatography.
Immunohistochemistry
Quiescent cultures grown on glass cover slips were stimulated with 5% FBS plus either TGF-b1 or vehicle for 18 h. [
3 H]thymidine (1 mCi/ml) was added during the last 6 h of treatment. The slides were ®xed in 4% paraformaldehyde, incubated in 1% hydrogen peroxide for 15 min at room temperature and digested with 0.1% trypsin for 5 min at 378C. After blocking in 1.5% normal horse serum for 30 min at room temperature, the slides were incubated with 1 : 25 diluted anti-mouse cyclin D1 antibody for 18 h at 48C. Antigen-antibody complexes were visualized using Vectastain ABC (peroxidase) kits (Vector Laboratories, Inc., Burlingame, CA). To visualize 3 H-thymidine-labeled nuclei, the slides were coated with autoradiographic emulsion (Eastman Kodak Company), developed afer 14 days and then stained with hematoxylin.
Immunoblotting and immunoprecipitation
Polyclonal rabbit antibody against human cyclin D1, monoclonal antibody against mouse cyclin D1 and polyclonal rabbit antibodies against Cdk4 and p27 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Antiserum against mouse cyclin D3 was prepared from rabbits, as previously described (Ko et al., 1995) . The anti-Cdk4 antiserum that was used for kinase assays was kindly provided by Dr Edward B Leof (Mayo Clinic, Rochester, MN). Polyclonal rabbit antibody against mouse p21 was kindly provided by Dr David E Hill (Oncogene Science, Inc., Cambridge, MA).
Cells were harvested by scraping and lysed in NP-40 buer (50 mM Tris at pH 7.5, 150 mM NaCl, 0.5% NP-40, 50 mM NaF, 1 mM Na-orthovanadate, 1 mM DTT, 1 mM PMSF, 1 mM benzamidine hydrochloride, and 25 mg/ml each of aprotinin, leupeptin, pepstatin A and soybean trypsin inhibitor) as previously described (Evers et al., 1996) . The lysates were clari®ed by centrifugation and protein concentrations were quantitated by the Bradford assay (Bio-Rad Laboratories, Hercules, CA). For immunoblotting, protein samples (50 mg) were resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS ± PAGE) and then transfer to Immobilon-P nylon membranes and probed with antibodies, as described elsewhere (Evers et al., 1996) . Proteins were visualized using the enhanced chemiluminescence (ECL) system (Amersham Life Science, Inc., Arlington Heights, IL) and exposed to XAR5 ®lm (Eastman Kodak Company, Rochester, NY).
For immunoprecipitation, protein samples (150 mg) were incubated with 1 mg of antibodies for 3 h at 48C followed by incubation for 2 h with protein A-Sepharose. Immunocomplexes were collected by centrifugation, washed three times in NP-40 buer and suspended in 20 ml of 26Laemmli buer (125 mM Tris at pH 6.8, 4% SDS, 20% glycerol and 10% bmercaptoethanol). After boiling for 5 min, proteins were resolved by SDS ± PAGE and analysed by immunoblotting with appropriate antibodies. Protein signals were quanti®ed using the Applied Imaging Lynx 5000 digital analysis system (Applied Imaging, Pittsburgh, PA).
Metabolic labeling
Pulse-labeling of proteins in mid-log phase cultures was determined 6 h after addition of TGF-b1 or vehicle. Three hours prior to harvesting, culture medium was changed to methionine-free DMEM supplemented with 5% FBS and 300 mCi/ml of [ 35 S]methionine in the presence or TGF-b1 or vehicle. Protein lysates were prepared in NP-40 buer and sample aliquots (200 mg) were immunoprecipitated with appropriate antibodies. Proteins were resolved by SDS ± PAGE, visualized by autoradiography and quanti®ed using the Lynx digital analysis system described above.
Cyclin D1 protein half-life was determined by pulse-chase experiments. Mid-log phase cultures were incubated for 3 h in methionine-free DMEM supplemented with 5% FBS and 300 mCi/ml of [ 35 S]methionine in the presence of TGF-b1 or vehicle. Cultures were washed three times followed by incubation in DMEM supplemented with 5% FBS and 2 mM unlabeled methionine plus TGF-b1 or vehicle. Protein lysates were collected at intervals and sample aliquots (200 mg) were incubated with 1 mg of anti-cyclin D1 antibody. Proteins were separated on SDS ± PAGE, visualized by autoradiography and quanti®ed using the Lynx digital image analysis system.
Kinase assays
Cdk4-associated pRB kinase activity was assayed as described elsewhere (Rhee et al., 1995; Ramalingam et al., 1997) . Brie¯y, cells were harvested into IP buer (50 mM HEPES at pH 7.5, 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 0.1% Tween-20, 10% glycerol, 1 mM DTT, 10 mg/ml leupeptin, 25 mg/ml aprotinin, 5 mg/ml pepstatin A, 10 mM b-glycerophosphate and 0.1 mM Naorthovanadate). Sample aliquots (500 mg) were ®rst cleared by incubation with S. aureus (Cowan) then precipitated with 5 ml of anti-Cdk4 antiserum. Immunocomplexes were adsorbed with protein A-Sepharose and washed four times in IP buer and twice with 50 mM HEPES (pH 7.5) and 1 mM DTT. The kinase assay was performed for 30 min at 308C in kinase buer (50 mM HEPES at pH 7.5, 1 mM NaF, 2.5 mM EGTA, 1 mM DTT, 10 mM b-glycerophosphate, 0.1 mM Na-orthovanadate and 10 mM MgCl 2 ) plus 1.5 mg of recombinant GSTpRB, 20 mM unlabeled ATP and 10 mCi of g-32 P-ATP (6000 Ci/mmol). Reactions were stopped with the addition of 26Laemmli buer. The proteins were boiled for 5 min, resolved by SDS ± PAGE and visualized by autoradiography.
RNA extraction and Northern blotting
Total RNA was extracted according to Chirgwin et al. (1979) . RNA samples (20 mg/lane) were separated by electrophoresis on denaturing agarose gels and blotted onto nitrocellulose membranes, as previously described . The blots were probed with human cyclin D1 cDNA probes labeled with g-32 P-dCTP (400 Ci/mM, Du-Pont-New England Nuclear) by the random primer extension method and signals were visualized by autoradiography.
